Onyx Pharmaceuticals, Inc. ( ONXX ) recently provided an update on its performance in 2012 and its plans for 2013. Kyprolis Off to a Strong Start Oncology product Kyprolis, which was
Originally posted here:
Catalyst-Filled 2013 for Onyx – Analyst Blog